Media coverage about Halyard Health (NYSE:HYH) has been trending somewhat positive recently, Accern Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Halyard Health earned a news sentiment score of 0.09 on Accern’s scale. Accern also assigned news coverage about the medical instruments supplier an impact score of 47.7759823783064 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Shares of Halyard Health (NYSE HYH) opened at $47.51 on Friday. The firm has a market cap of $2,227.07, a P/E ratio of 39.92, a PEG ratio of 2.50 and a beta of 1.71. Halyard Health has a one year low of $35.24 and a one year high of $50.99. The company has a quick ratio of 1.19, a current ratio of 2.13 and a debt-to-equity ratio of 0.49.
Several research analysts have commented on HYH shares. ValuEngine upgraded shares of Halyard Health from a “hold” rating to a “buy” rating in a research report on Saturday, November 4th. Zacks Investment Research cut shares of Halyard Health from a “buy” rating to a “hold” rating in a research report on Wednesday, January 3rd. TheStreet cut shares of Halyard Health from a “b-” rating to a “c+” rating in a research report on Monday, October 30th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and issued a $52.00 price target on shares of Halyard Health in a research note on Friday, November 3rd. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $49.00.
TRADEMARK VIOLATION WARNING: This piece of content was originally published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The correct version of this piece of content can be accessed at https://stocknewstimes.com/2018/02/18/halyard-health-hyh-given-daily-news-impact-score-of-0-09.html.
Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.
Receive News & Ratings for Halyard Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health and related companies with MarketBeat.com's FREE daily email newsletter.